Seoulin Bioscience Co.,Ltd.

KOSDAQ:A038070 Stock Report

Market Cap: ₩72.5b

Seoulin BioscienceLtd Dividends and Buybacks

Dividend criteria checks 1/6

Seoulin BioscienceLtd is a dividend paying company with a current yield of 1.16% that is well covered by earnings.

Key information

1.2%

Dividend yield

1.5%

Buyback Yield

Total Shareholder Yield2.7%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ratio31%

Recent dividend and buyback updates

Three Days Left Until Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Trades Ex-Dividend

Dec 25
Three Days Left Until Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Trades Ex-Dividend

Recent updates

Concerns Surrounding Seoulin BioscienceLtd's (KOSDAQ:038070) Performance

Mar 25
Concerns Surrounding Seoulin BioscienceLtd's (KOSDAQ:038070) Performance

Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Low P/S No Reason For Excitement

Dec 04
Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Low P/S No Reason For Excitement

Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Is An Attractive Dividend Stock - Here's Why

May 03
Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Is An Attractive Dividend Stock - Here's Why

Should Weakness in Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Mar 13
Should Weakness in Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Introducing Seoulin BioscienceLtd (KOSDAQ:038070), A Stock That Climbed 54% In The Last Year

Feb 15
Introducing Seoulin BioscienceLtd (KOSDAQ:038070), A Stock That Climbed 54% In The Last Year

Is Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) A Great Dividend Stock?

Jan 20
Is Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) A Great Dividend Stock?

Three Days Left Until Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Trades Ex-Dividend

Dec 25
Three Days Left Until Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Trades Ex-Dividend

Is Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Dec 06
Is Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: A038070 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: A038070's dividend payments have increased, but the company has only paid a dividend for 6 years.


Dividend Yield vs Market

Seoulin BioscienceLtd Dividend Yield vs Market
How does A038070 dividend yield compare to the market?
SegmentDividend Yield
Company (A038070)1.2%
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)3.8%
Industry Average (Biotechs)0.6%
Analyst forecast (A038070) (up to 3 years)n/a

Notable Dividend: A038070's dividend (1.16%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.19%).

High Dividend: A038070's dividend (1.16%) is low compared to the top 25% of dividend payers in the KR market (3.89%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (31.1%), A038070's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: A038070 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/29 06:55
End of Day Share Price 2025/05/29 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Seoulin Bioscience Co.,Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sung Hwan ChoiKyobo Securities Co., Ltd
Ju-Hong ChoeLS Securities Co., Ltd.
Seung KimSK Securities Co., Ltd.